Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-41,176
Closed -$4.23M 304
2025
Q2
$4.23M Buy
+41,176
New +$4.54M 0.01% 594
2023
Q3
Sell
-55,050
Closed -$3.55M 1081
2023
Q2
$3.55M Sell
55,050
-2,400
-4% -$161K 0.01% 624
2023
Q1
$3.64M Sell
57,450
-2,400
-4% -$140K 0.01% 641
2022
Q4
$2.9M Buy
59,850
+600
+1% +$29.9K 0.01% 711
2022
Q3
$2.73M Buy
59,250
+900
+2% +$46.7K 0.01% 707
2022
Q2
$2.86M Sell
58,350
-14,250
-20% -$734K 0.01% 712
2022
Q1
$4.08M Buy
72,600
+41,400
+133% +$2.35M 0.01% 704
2021
Q4
$2.16M Hold
31,200
0.01% 829
2021
Q3
$1.94M Hold
31,200
0.01% 859
2021
Q2
$1.4M Hold
31,200
﹤0.01% 942
2021
Q1
$1.07M Sell
31,200
-3,300
-10% -$115K ﹤0.01% 969
2020
Q4
$1.22M Sell
34,500
-9,600
-22% -$298K ﹤0.01% 940
2020
Q3
$1.26M Sell
44,100
-4,500
-9% -$121K ﹤0.01% 894
2020
Q2
$1.15M Hold
48,600
﹤0.01% 932
2020
Q1
$883K Buy
+48,600
New +$1.26M ﹤0.01% 874
2019
Q4
Sell
-17,400
Closed -$439K 1183
2019
Q3
$439K Buy
+17,400
New +$495K ﹤0.01% 1117

Other funds holding CRVL

Axa's CRVL Position: Q3 2025 in Review

Axa sold out of CorVel (CRVL) in Q3 2025, closing a stake of 41,176 shares — an estimated $4.23M sold.

Axa first reported a position in CRVL in Q3 2019 and held it in 16 quarters. The position peaked at $4.23M in Q2 2025. 284 funds tracked by Wall St. Rank hold CRVL as of Q3 2025.

  • Axa reported no remaining CorVel position as of Q3 2025 after selling out during the quarter.
  • Axa sold 41,176 CorVel shares in Q3 2025, an estimated $4.23M.
  • Axa first reported a position in CorVel in Q3 2019 and held it in 16 quarters.
  • Axa's CorVel position peaked at $4.23M in Q2 2025.
  • 284 funds tracked by Wall St. Rank held CorVel as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.